Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
10.8M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
1.34M
-
Shares change
-
-62.7K
-
Total reported value, excl. options
-
$19.6M
-
Value change
-
-$1.63M
-
Number of buys
-
12
-
Number of sells
-
-7
-
Price
-
$14.60
Significant Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q2 2021
24 filings reported holding LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share as of Q2 2021.
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.34M shares
of 10.8M outstanding shares and own 12.42% of the company stock.
Largest 10 shareholders include Corriente Advisors, LLC (656K shares), VANGUARD GROUP INC (269K shares), GWM Advisors LLC (151K shares), GEODE CAPITAL MANAGEMENT, LLC (55.5K shares), MORGAN STANLEY (52.3K shares), Redmond Asset Management, LLC (45.5K shares), WOLFF WIESE MAGANA LLC (28.3K shares), Bank of New York Mellon Corp (26.8K shares), BlackRock Inc. (25.1K shares), and NORTHERN TRUST CORP (12.6K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.